Natco Pharma Ltd. (NATCOPHARM)
Market Closed
2 Mar, 10:00
XNSE XNSE Primary MSE ₹
956. 25
-32.25
-3.26%
₹
178.38B Market Cap
13.93 P/E Ratio
5% Div Yield
1,073,075 Volume
0 Eps
₹ 988.5
Previous Close Day Range
925.15 967.85
Year Range
726.8 1,059
Want to track NATCOPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NATCOPHARM earnings report is expected in 87 days (29 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 17.1 | - |
| | | 5.4 | - |
| | | 8.67 | 8.46 |
| | | - | - |
| | | 24.56 | 28.94 |
| | | 24.56 | - |
| | | 24.56 | - |
| | | - | - |
| | | - | - |
| | | 13.36 | 7.43 |
| | | 31.5 | 37.81 |
| | | - | - |
| | | - | - |
| | | 16.01 | 21.56 |
| | | - | - |
| | | - | - |
| | | 1.87 | 3.8 |
| | | 3.44 | 10.12 |
| | | 9.3 | 9.34 |
NATCOPHARM Earnings Reports FAQ
What is the earnings per share (EPS) for NATCOPHARM?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately -0.82%, reflecting the NATCOPHARM's performance and XNSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-29, based on the NATCOPHARM's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 8.46 per share, reported on 2026-02-12. For dividend history, visit the NATCOPHARM Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 113.03, calculated based on the most recent stock price of ₹956.25.
